Gates Foundation Strategic Investment Fund Logo

Gavi / Serum

The foundation has partnered with Gavi and the Serum Institute of India (“SII”) to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for low- and middle-income countries. The collaboration was expanded in August 2020 Read More

Enko Chem

Enko Chem is an early stage agricultural life sciences company that is looking to apply DNA encoded library technology to identify and develop new, safer chemical compounds that protect crops from pests and disease. The foundation invested in the Company Read More

Eastside Preparatory School

Eastside Preparatory School is a college-preparatory school located in Kirkland, Washington. The foundation provided a loan to support an expansion of the organization’s campus. Investment Date: February 2017


BioNTech is focused on combining ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and other serious diseases. The Foundation is working with BioNTech on developing preclinical vaccines and immunotherapy candidates to prevent HIV and tuberculosis infection as Read More

Adjuvant Global Health Technology Fund

The foundation has committed to further support the Global Health Investment Fund model by investing as an anchor LP in Adjuvant. Adjuvant is a private investment fund focused on late-stage life sciences investments to address global health challenges. The Fund invests Read More


Halodoc is an online-to-offline (“O2O”) health delivery marketplace launched in 2016 and based in Jakarta, Indonesia. The Company aims to improve accessibility, affordability, and quality of healthcare for at least 100 million Indonesians by systemically addressing inefficiencies and resource misallocation Read More


Atreca is a biotechnology company that employs its proprietary discovery platform to generate and develop therapeutics based on its ability to rapidly characterize the human adaptive immune response at the single cell level.  The Atreca platform enables the high-throughput phylogenetic Read More

Vedanta Biosciences

Vedanta Biosciences is creating a new class of drugs to modulate the human microbiome. Vedanta is pioneering the rational design of drugs made of defined consortia of bacteria that are essential dwellers of the gut ecosystem that perform critical functions Read More

Lyndra Therapeutics

Lyndra Therapeutics is developing an orally administered dosage form designed to deliver sustained, steady-state release of one or more drugs for up to a week or longer while temporarily residing in the stomach. The foundation invested in the company to Read More

Hester Biosciences Africa Limited

Hester Biosciences Africa Limited (“Hester Africa”), a newly-formed Tanzanian company and a wholly-owned subsidiary of Hester Biosciences Limited (“Hester”), is building an animal vaccine manufacturing facility near Dar es Salaam. Hester has a 20-year track record manufacturing and distributing livestock Read More